Dr. Pier Vitale Nuzzo received his MD, M.Sc., and Ph.D. in
Transitional Medicine in Oncology and Hematology from the University of Genoa,
Italy, in 2009, 2015, and 2019, respectively. After completing his medical
residency in Medical Oncology, he joined the Center for Functional Cancer
Epigenetics, Dana-Farber Cancer Institute of Boston. He is now the Instructor
in Pathology and Laboratory Medicine, at Weill Cornell Medicine. He is also a
Postdoctoral Research Fellow at Dana-Farber Cancer Institute, where he is
working on clinical and translational research projects in kidney and bladder
cancers. He is an active member of the American Society of Clinical Oncology
(ASCO), the European Society for Medical Oncology (ESMO), and the Society for
Immunotherapy of Cancer (SITC). His research is focused on cell-free methylated
DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq), a
non-invasive, cost-effective, and sensitive assay for genome-wide
bisulfite-free plasma DNA methylation.
